esmolol has been researched along with Coronary Heart Disease in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (52.63) | 18.7374 |
| 1990's | 15 (39.47) | 18.2507 |
| 2000's | 3 (7.89) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Minge, C; Mitrovic, V; Oehm, E; Schlepper, M; Thürmann, P | 1 |
| Frasco, PE; Leone, BJ; McRae, RL; Smith, LR; Spahn, DR; White, WD | 1 |
| Duane, DT; Grounds, RM; Redwood, SR | 1 |
| Guerrero, JL; Levangie, MW; Picard, MH; Weissman, NJ; Weyman, AE | 1 |
| Chen, C; Chen, L; Chen, M; de Prada, VA; Feng, YJ; Gillam, L; Ma, L; Waters, D | 1 |
| Abdullah, EE; Pollick, C | 1 |
| Brooker, RF; Foreman, AS; Hewitt, C; McCall, WV; Murphy, BA; Royster, RL; Zvara, DA | 1 |
| Mehlhorn, U | 1 |
| Chen, FG; Cheong, KF; Ti, LK | 1 |
| Haberbosch, W; Mitrovic, V; Oehm, E; Pitschner, H; Thormann, J | 1 |
| Bhan, A; Chauhan, S; Rao, BH; Saxena, N; Singh, RS | 1 |
| Hamm, C; Mitrovic, V; Oehm, E; Pitschner, H; Thormann, J | 1 |
| Low, CJ; Stewart, RA; Wilkins, GT; Williams, MJ | 1 |
| Evans, R; Fernandes, NO; Kurian, SM; Sherry, KM | 1 |
| Barth, C; Castello, R; Kern, MJ; Labovitz, AJ; Ojile, M | 1 |
| Rush, W; Sidi, A | 1 |
| Boden, WE; Califf, R; Crawford, MH; Hakki, AH; Iskandrian, AS; Labovitz, A; O'Connor, C; Scanlon, PJ; Sutton, R; Wallis, DE | 1 |
| Brown, MD; Mihm, FG; Rosenthal, MH; Sandhu, JS | 1 |
| Jacobs, JR | 1 |
| Martineau, RJ; Miller, DR | 1 |
| Cantineau, JP; Couderc, E; Desmonts, JM; Kirsteter, P; Lagoueyte, JF; Lefèvre, P; Marty, J | 1 |
| van Wezel, HB | 1 |
| Davis, RF; Sidi, A | 1 |
| Antman, EM; Braunwald, E; Kirshenbaum, JM; Kloner, RA | 1 |
| Greenspan, AM; Horowitz, LN; Laddu, A; Senior, S; Spielman, SR; Steck, J | 1 |
| Gorczynski, RJ | 1 |
| Antman, EM; Braunwald, E; Kirshenbaum, J; Kloner, RA; Lange, R | 1 |
| Keefe, DL; Somberg, JC | 1 |
| Blanski, L; Kirshenbaum, J; Laddu, AR; MacCosbe, P; Sung, RJ; Turlapaty, P | 1 |
| Angaran, DM; Schultz, NJ; Tschida, VH | 1 |
| Allin, D; Bemis, CE; Hakki, AH; Heo, J; Hua, TA; Iskandrian, AS; Kane-Marsch, S; Panidis, I; Toole, JG | 1 |
| Clements, F; Croughwell, N; de Bruijn, NP; Drissel, DA; Reves, JG | 1 |
| Covinsky, JO | 1 |
| Askenazi, J; Hoff, J; Hua, TA; Laddu, A; MacCosbe, PE; Turlapaty, P | 1 |
| Laddu, A; Lee, R; Murthy, VS; Singh, B; Turlapaty, P | 1 |
| Antman, EM; Kirshenbaum, JM; Kloner, RF; McGowan, N | 1 |
| Laddu, A; Turlapaty, P; Viray, R | 1 |
| Blanski, L; Laddu, A; Lutz, J | 1 |
6 review(s) available for esmolol and Coronary Heart Disease
| Article | Year |
|---|---|
Basic pharmacology of esmolol.
Topics: Adrenergic beta-Antagonists; Animals; Coronary Disease; Dogs; Electrophysiology; Esterases; Guinea Pigs; Heart Atria; Heart Conduction System; Hemodynamics; Humans; Kinetics; Myocardial Contraction; Oxygen Consumption; Propanolamines; Structure-Activity Relationship | 1985 |
Experimental and clinical observations on the efficacy of esmolol in myocardial ischemia.
Topics: Adrenergic beta-Antagonists; Animals; Arterial Occlusive Diseases; Clinical Trials as Topic; Coronary Disease; Disease Models, Animal; Dogs; Hemodynamics; Humans; Infusions, Parenteral; Myocardial Infarction; Oxygen Consumption; Propanolamines; Syndrome; Time Factors | 1985 |
Esmolol hydrochloride: an ultrashort-acting, beta-adrenergic blocking agent.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Chemical Phenomena; Chemistry; Coronary Disease; Drug Interactions; Female; Heart; Hemodynamics; Humans; Hypertension; Kinetics; Lactation; Myocardial Infarction; Postoperative Complications; Pregnancy; Pregnancy Complications, Cardiovascular; Propanolamines; Tachycardia | 1986 |
Esmolol: a titratable short-acting intravenous beta blocker for acute critical care settings.
Topics: Adrenergic beta-Antagonists; Animals; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Coronary Disease; Critical Care; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Hemodynamics; Humans; Hypertension; Propanolamines; Tachycardia, Supraventricular | 1987 |
Esmolol: a short-acting titratable beta-blocker in acute myocardial ischemia.
Topics: Acute Disease; Adrenergic beta-Antagonists; Coronary Disease; Humans; Propanolamines | 1988 |
Esmolol, the first ultra-short-acting intravenous beta blocker for use in critically ill patients.
Topics: Coronary Disease; Critical Care; Hemodynamics; Humans; Hypertension; Propanolamines; Tachycardia, Supraventricular | 1988 |
12 trial(s) available for esmolol and Coronary Heart Disease
| Article | Year |
|---|---|
[Anti-ischemia effects of gallopamil and esmolol in an intra-individual comparison in patients with coronary heart disease].
Topics: Adrenergic beta-Antagonists; Aged; Aldosterone; Atrial Natriuretic Factor; Coronary Angiography; Coronary Circulation; Coronary Disease; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Gallopamil; Hemodynamics; Humans; Infusions, Intravenous; Lactates; Lactic Acid; Male; Middle Aged; Myocardial Ischemia; Norepinephrine; Propanolamines; Renin; Single-Blind Method | 1994 |
The effect of esmolol on ST-segment depression and arrhythmias after electroconvulsive therapy.
Topics: Adrenergic beta-Antagonists; Aged; Coronary Disease; Double-Blind Method; Electrocardiography, Ambulatory; Electroconvulsive Therapy; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Myocardial Ischemia; Premedication; Propanolamines; Risk Factors; Sympathetic Nervous System; Tachycardia | 1997 |
Improved myocardial protection using continuous coronary perfusion with normothermic blood and beta-blockade with esmolol.
Topics: Adrenergic beta-Antagonists; Animals; Cardioplegic Solutions; Coronary Artery Bypass; Coronary Disease; Disease Models, Animal; Dogs; Edema, Cardiac; Female; Heart Arrest, Induced; Heart-Assist Devices; Humans; Male; Myocardial Reperfusion Injury; Propanolamines; Temperature; Ventricular Function, Left | 1997 |
Comparison of the potassium channel blocker tedisamil with the beta-adrenoceptor blocker esmolol and the calcium antagonist gallopamil in patients with coronary artery disease.
Topics: Adrenergic beta-Antagonists; Blood Gas Analysis; Bridged Bicyclo Compounds, Heterocyclic; Calcium Channel Blockers; Catecholamines; Coronary Disease; Cyclopropanes; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Female; Gallopamil; Hemodynamics; Humans; Lactic Acid; Male; Middle Aged; Potassium Channel Blockers; Propanolamines; Treatment Outcome | 1998 |
A comparison of esmolol & diltiazem for heart rate control during coronary revascularisation on beating heart.
Topics: Adrenergic beta-Antagonists; Adult; Calcium Channel Blockers; Coronary Disease; Diltiazem; Heart Rate; Hemodynamics; Humans; Monitoring, Intraoperative; Myocardial Revascularization; Propanolamines | 1999 |
Potassium channel openers and blockers in coronary artery disease. Comparison to betablockers and calcium antagonists.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Angina Pectoris; Anti-Arrhythmia Agents; Atenolol; Benzopyrans; Bridged Bicyclo Compounds, Heterocyclic; Calcium Channel Blockers; Cardiotonic Agents; Coronary Disease; Cyclopropanes; Dihydropyridines; Electrocardiography; Exercise Test; Gallopamil; Hemodynamics; Humans; Middle Aged; Myocardium; Oxygen Consumption; Potassium Channel Blockers; Potassium Channels; Propanolamines; Time Factors; Vasodilator Agents | 2000 |
Randomised comparison of the effects of nicardipine and esmolol on coronary artery wall stress: implications for the risk of plaque rupture.
Topics: Adrenergic beta-Antagonists; Aged; Blood Pressure; Calcium Channel Blockers; Coronary Angiography; Coronary Disease; Coronary Vessels; Female; Heart Rate; Humans; Male; Middle Aged; Nicardipine; Propanolamines; Stress, Mechanical; Ultrasonography, Interventional | 2000 |
The effect of an infusion of esmolol on the incidence of myocardial ischaemia during tracheal extubation following coronary artery surgery.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Cardiopulmonary Bypass; Coronary Disease; Device Removal; Female; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Intubation, Intratracheal; Male; Middle Aged; Myocardial Ischemia; Postoperative Care; Postoperative Complications; Propanolamines | 2001 |
Failure of adjuvant heparin to reduce myocardial ischemia in the early treatment of patients with unstable angina.
Topics: Adrenergic beta-Antagonists; Aged; Angina, Unstable; Chi-Square Distribution; Coronary Disease; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Heparin; Humans; Male; Middle Aged; Propanolamines; Regression Analysis; Retrospective Studies; Time Factors | 1991 |
Experimental and clinical observations on the efficacy of esmolol in myocardial ischemia.
Topics: Adrenergic beta-Antagonists; Animals; Arterial Occlusive Diseases; Clinical Trials as Topic; Coronary Disease; Disease Models, Animal; Dogs; Hemodynamics; Humans; Infusions, Parenteral; Myocardial Infarction; Oxygen Consumption; Propanolamines; Syndrome; Time Factors | 1985 |
Clinical experience with esmolol, a short-acting beta-adrenergic blocker in cardiac arrhythmias and myocardial ischemia.
Topics: Adrenergic beta-Antagonists; Aged; Arrhythmias, Cardiac; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Male; Middle Aged; Propanolamines; Propranolol; Random Allocation; Time Factors | 1986 |
Esmolol: a titratable short-acting intravenous beta blocker for acute critical care settings.
Topics: Adrenergic beta-Antagonists; Animals; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Coronary Disease; Critical Care; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Hemodynamics; Humans; Hypertension; Propanolamines; Tachycardia, Supraventricular | 1987 |
22 other study(ies) available for esmolol and Coronary Heart Disease
| Article | Year |
|---|---|
Is esmolol cardioprotective? Tolerance of pacing tachycardia, acute afterloading and hemodilution in dogs with coronary stenosis.
Topics: Adrenergic beta-Antagonists; Animals; Cardiac Pacing, Artificial; Coronary Disease; Dogs; Heart Conduction System; Heart Rate; Hemodilution; Multivariate Analysis; Myocardial Contraction; Propanolamines; Tachycardia; Ventricular Function, Left | 1993 |
Esmolol aids extubation in intensive care patient with ischaemic pulmonary oedema.
Topics: Adrenergic beta-Antagonists; Coronary Disease; Critical Care; Electrocardiography; Humans; Intubation, Intratracheal; Male; Middle Aged; Propanolamines; Pulmonary Edema; Ventilator Weaning | 1996 |
Effect of beta-blockade on dobutamine stress echocardiography.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Coronary Disease; Disease Models, Animal; Dobutamine; Dogs; Echocardiography; Hemodynamics; Infusions, Intravenous; Propanolamines | 1996 |
Effects of beta-blockade and atropine on ischemic responses in left ventricular regions subtending coronary stenosis during dobutamine stress echocardiography.
Topics: Adrenergic beta-Antagonists; Animals; Atropine; Cardiotonic Agents; Coronary Circulation; Coronary Disease; Dobutamine; Echocardiography; Lactic Acid; Myocardial Contraction; Myocardial Ischemia; Myocardium; Observer Variation; Oxygen Consumption; Propanolamines; Sensitivity and Specificity; Swine; Ventricular Function, Left | 1996 |
Symptomatic and hemodynamic recovery following dobutamine stress echo: benefit of low-dose esmolol administration.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Coronary Disease; Dobutamine; Dose-Response Relationship, Drug; Echocardiography; Exercise Test; Female; Hemodynamics; Humans; Hypotension; Infusions, Intravenous; Male; Middle Aged; Propanolamines; Retrospective Studies; Treatment Outcome | 1997 |
Esmolol resistance during anesthesia for thoracoscopically assisted coronary artery bypass grafting.
Topics: Adrenergic beta-Antagonists; Adult; Anesthesia, Local; Coronary Artery Bypass; Coronary Disease; Drug Resistance; Heart Rate; Humans; Infusions, Intravenous; Intraoperative Complications; Male; Middle Aged; Propanolamines; Tachycardia; Thoracoscopy | 1998 |
Attenuation of myocardial ischemia during coronary occlusion by ultrashort-acting beta adrenergic blockade.
Topics: Adrenergic beta-Antagonists; Angioplasty, Balloon, Coronary; Coronary Disease; Echocardiography, Doppler; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Contraction; Propanolamines; Stroke Volume | 1991 |
Decreased regional lactate production and output due to intracoronary continuous infusion of esmolol during acute coronary occlusion in dogs.
Topics: Adrenergic beta-Antagonists; Animals; Blood Glucose; Blood Pressure; Cardiac Output; Coronary Circulation; Coronary Disease; Dogs; Female; Heart Rate; Lactates; Male; Myocardium; Oxygen; Oxygen Consumption; Potassium; Propanolamines; Stroke Volume; Vascular Resistance; Ventricular Function, Left | 1991 |
Short-acting beta-adrenergic blockade as initial drug therapy in pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Coronary Disease; Epinephrine; Hormones, Ectopic; Humans; Hypertension; Male; Middle Aged; Pheochromocytoma; Propanolamines | 1990 |
Negative inotropic effects of esmolol.
Topics: Adrenergic beta-Antagonists; Animals; Coronary Disease; Dogs; Hemodynamics; Propanolamines | 1989 |
Bolus administration of esmolol for the treatment of intraoperative myocardial ischaemia.
Topics: Adrenergic beta-Antagonists; Aged; Anesthesia, Intravenous; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Foot; Humans; Hypertension; Injections, Intravenous; Intraoperative Complications; Ischemia; Male; Propanolamines | 1989 |
[Esmolol attenuation of hemodynamic changes in resuscitation of hypertensive and coronary patients].
Topics: Adrenergic beta-Antagonists; Coronary Disease; Hemodynamics; Humans; Hypertension; Intraoperative Complications; Propanolamines; Resuscitation | 1989 |
Hypertensive crisis during coronary vessel surgery.
Topics: Adrenergic beta-Antagonists; Coronary Artery Bypass; Coronary Disease; Coronary Vessels; Humans; Hypertension; Intraoperative Period; Myocardial Infarction; Nifedipine; Nitroprusside; Propanolamines; Vasoconstrictor Agents | 1989 |
Esmolol decreases the adverse effects of acute coronary artery occlusion on myocardial metabolism and regional myocardial blood flow in dogs.
Topics: Analysis of Variance; Animals; Collateral Circulation; Coronary Circulation; Coronary Disease; Disease Models, Animal; Dogs; Female; Hemodynamics; Lactates; Male; Myocardium; Propanolamines; Random Allocation; Receptors, Adrenergic, beta | 1988 |
Use of an ultra short-acting beta-blocker in patients with acute myocardial ischemia.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Coronary Disease; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Propanolamines; Time Factors | 1985 |
Electrophysiology of esmolol.
Topics: Adrenergic beta-Antagonists; Atrioventricular Node; Blood Pressure; Coronary Disease; Electrocardiography; Electrophysiology; Female; Heart Conduction System; Humans; Infusions, Parenteral; Male; Middle Aged; Propanolamines; Sinoatrial Node | 1985 |
Esmolol: a novel ultra-short-acting beta-blocking agent.
Topics: Adrenergic beta-Antagonists; Coronary Disease; Humans; Oxygen Consumption; Propanolamines | 1986 |
Effects of esmolol on patients with left ventricular dysfunction.
Topics: Adrenergic beta-Antagonists; Aged; Blood Pressure; Cardiac Output; Coronary Disease; Female; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Propanolamines; Radionuclide Imaging; Vascular Resistance | 1986 |
Pharmacokinetics of esmolol in anesthetized patients receiving chronic beta blocker therapy.
Topics: Adrenergic beta-Antagonists; Anesthesia, General; Coronary Artery Bypass; Coronary Disease; Half-Life; Humans; Intraoperative Care; Kinetics; Propanolamines | 1987 |
Esmolol: a novel cardioselective, titratable, intravenous beta-blocker with ultrashort half-life.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Blood Pressure; Coronary Disease; Half-Life; Humans; Kinetics; Propanolamines; Sympathetic Nervous System; Tachycardia, Sinus | 1987 |
Hemodynamic effects of esmolol, an ultrashort-acting beta blocker.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Coronary Disease; Heart Function Tests; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Propanolamines | 1987 |
Use of an ultrashort-acting beta-receptor blocker (esmolol) in patients with acute myocardial ischemia and relative contraindications to beta-blockade therapy.
Topics: Adrenergic beta-Antagonists; Aged; Blood Pressure; Cardiac Output; Coronary Disease; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Propanolamines; Pulmonary Wedge Pressure | 1988 |